NEVVI Medicare utilization intelligence
Compare this code with others
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS

Jump to the result views

G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l HCPCS · Chemotherapy treatment
Classification Treatment › Chemotherapy › Chemotherapy Administration (CMS RBCS)
First observed 2016
National scale 102,707 services · est. ▲ 5.9% YoY · 16,200 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 51,103 observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Filter results:
Market summary
Market Brief G0498
A shareable PDF report summarizing this market’s size, trends, and providers.
Preview this Brief →

This market's Overview — its estimated all-Medicare volume, national benchmarks, and what the field charges and is paid — is part of Explore.

See what Medicare pays

An Explore subscription, $249 a seat a year, opens the Overview on every code, group and clinician page, including what the market charges and is paid.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Subscribe to Explore →

Included in Explore. Part of a Deep Dive.
Continue from here

Browse Medicare billing by specialty →